Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
FULC | Fulcrum Therapeutics, Inc. | President & Chief Executive Officer, Director | $1.5M | +$492K | +48.8% | Jul 3, 2024 |
PHASQ | PhaseBio Pharmaceuticals Inc | Director | May 19, 2023 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|